CHRISTOPHER JOHN KENNEY - 23 Aug 2021 Form 3 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Role
Chief Medical Officer
Signature
/s/ Cassandra Robinson Attorney-in-fact
Issuer symbol
XENE
Transactions as of
23 Aug 2021
Net transactions value
$0
Form type
3
Filing time
25 Aug 2021, 16:05:54 UTC
Next filing
21 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XENE No securities are beneficially owned. 0 23 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XENE No securities are beneficially owned. 23 Aug 2021 N/A $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.